- Home
- LTRN vs RADX Comparison
LTRN vs RADX Comparison
Compare LTRN & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- RADX
- Stock Information
- Founded
- LTRN 2013
- RADX 2021
- Country
- LTRN United States
- RADX Australia
- Employees
- LTRN N/A
- RADX N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- RADX
- Sector
- LTRN Health Care
- RADX
- Exchange
- LTRN Nasdaq
- RADX NYSE
- Market Cap
- LTRN 36.0M
- RADX 32.5M
- IPO Year
- LTRN 2020
- RADX N/A
- Fundamental
- Price
- LTRN $3.74
- RADX $4.25
- Analyst Decision
- LTRN Strong Buy
- RADX Strong Buy
- Analyst Count
- LTRN 1
- RADX 2
- Target Price
- LTRN $25.00
- RADX $13.50
- AVG Volume (30 Days)
- LTRN 281.3K
- RADX 22.4K
- Earning Date
- LTRN 08-07-2025
- RADX 02-26-2025
- Dividend Yield
- LTRN N/A
- RADX N/A
- EPS Growth
- LTRN N/A
- RADX N/A
- EPS
- LTRN N/A
- RADX N/A
- Revenue
- LTRN N/A
- RADX $204,609.00
- Revenue This Year
- LTRN N/A
- RADX N/A
- Revenue Next Year
- LTRN N/A
- RADX N/A
- P/E Ratio
- LTRN N/A
- RADX N/A
- Revenue Growth
- LTRN N/A
- RADX N/A
- 52 Week Low
- LTRN $2.55
- RADX $3.50
- 52 Week High
- LTRN $6.12
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- LTRN 63.62
- RADX N/A
- Support Level
- LTRN $3.21
- RADX N/A
- Resistance Level
- LTRN $3.75
- RADX N/A
- Average True Range (ATR)
- LTRN 0.24
- RADX 0.00
- MACD
- LTRN 0.07
- RADX 0.00
- Stochastic Oscillator
- LTRN 98.65
- RADX 0.00
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.